TipRanks
Go Ultimate55% OFF
Belite Bio logo

Belite Bio: Valuation, Funding & Investors

Belite Bio, Inc is a clinical-stage drug development company dedicated to creating novel therapeutics for degenerative retinal diseases with significant unmet medical needs, such as Stargardt disease and geographic atrophy in advanced dry age-related macular degeneration. The company is also involved in developing treatments for specific metabolic diseases, leveraging its expertise in RBP4 inhibition as a mechanism of action.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$125M
Total Funding Rounds
1
Latest Funding Amount
$125M
Latest Funding Round
Investment

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 08, 2025Investment$125.00M―

Investors

Investor NameFunding Round
Marshall WaceInvestment
Eventide Asset ManagementInvestment
RA Capital ManagementInvestment
RTW InvestmentsInvestment
Soleus CapitalInvestment
Vestal Point CapitalInvestment

Similar Companies

A snapshot of private companies similar to Belite Bio, helping you discover and navigate related company profiles.

Related News and Analysis